Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

National Institute for Health and Care Excellence NICE logo

NICE no for new eye disease drug

Institute says ‘gaps and uncertainties’ in the treatment’s evidence directed its decision

From measurement to management

How technology is revolutionising personal healthcare

- PMLiVE

Astellas forms new US corporate affairs unit

Jeff Winton will lead the department, which adds two newemployees

- PMLiVE

The blame game

In the 'healthcare spending crisis' it’s important to look beyond sensationalist headlines

Wearables: the tangible product of the patient revolution

As the relationship between the patient and his doctor evolve, we look at how new technology is playing its part

- PMLiVE

Overcoming quantitative pricing limitations

Choosing an accurate price for a product without a therapeutic equivalent can feel like a lead in the dark

- PMLiVE

Sophia Genetics names Marylin Mermod Schule as CFO

Mermod Schule is former deputy director of Benjamin de Rothschild Bank

- PMLiVE

Becoming a socially-active pharmaceutical company

A guest blog from LEO Pharma Spain on patient focus and its use of social networks

- PMLiVE

Research Partnership promotes Will Tolley

He moves up to associate director of quantitative research

- PMLiVE

Novel anticoagulant antidotes prove their worth

Reversal agents from Portola and BMS and Boehringer shine in late-stage clinical trials

- PMLiVE

Former Sanofi CEO Viehbacher takes health investment role

Willlead the Bertarelli family's $2bn Gurnet Point Capital fund

- PMLiVE

FDA gives the nod to TMC’s antiplatelet drug

Kengreal approved in the US three months after it got the green light in Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links